Kaigene
kaigene.com
Biologics & Biosimilars
Biotechnology
Health Care
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$55M
2 rounds on record
Latest round
$55M
Venture round · Sep 2026 · 1 mo ago
Team
20
US Form 5500 (plan participants) · Dec 2025 · +43% in a year
Backers
1
Atinum Investment
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 14
New executive Jihoon Park, Executive Officer · SEC Form D
Sep 30
Raised a round Venture round $55M · SEC Form D
2025
Team of 20 was 14 · US Form 5500 (plan participants)
Mar 15, 2022
Took on debt financing $1.4M · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2026 | $55M | — | SEC Form D |
| Debt Financing | Mar 2022 | $1.4M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Kaigene, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Minjae ShinExecutive Officer, DirectorSEC Form D
Jihoon ParkExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Oruka Therapeutics
Similar startupsby what they do, their industry and backers
Who We Are Our Pipeline Overview Presentations and Publications Join Us Investors Overview Press Releases Events & Presentations Stock…
리가켐 바이오사이언스는 신약개발에 30년 이상 헌신하며 혁신적인 기술과 Open Innovation을 통해 글로벌 신약개발의 새로운 길을 개척하고 있습니다.
본문 바로가기 HOME 회사소개 기업소개 기업소개 IMBiologics Innovative Medicines based on ImmunoModulatory Biologics 당사는 2020년 8월 설립된 혁신 항체신약 개발 전문기업으로, 『최적 항체…
Home Technology Antibody Drug Conjugates Innovative Platform - ‘OptiLinked’ FDCs Additional Products & Applications ANT-045, Antikor’s…
COMPANY NEWS October 21, 2026 October 21, 2026 CureLab Appoints Markus Puhlman, M.D., MBA, to Scientific Advisory Board Oncology…
Case Studies About Contact Start Your Trial 8,045,092 regulatory pages 44 regulatory databases 10 regulatory agencies Overview We help our…
Visa sponsorship
1
H-1B filings in 12 months
$73k
Median offered salary
0
Open roles in United States
Who they sponsor
Other biological scientists
1
In the register as KAIGENE, INC, Rockville, MD
Other sponsors in the same field
Regeneron Pharmaceuticals 316 filings
Kashiv Biosciences 17 filings
Rani Therapeutics 2 filings
SK Life Science 1 filings
Alert me
US Department of Labor · latest filing Aug 18, 2025 · Visa details by country
Overview
ABOUT US Overview Vision Our Leader SCIENCE Our Science Autoimmune Disease Our Platform R&D Strategy PIPELINE CAREER NEWS News&Notice CONTACT US ©2026 Kaigene, Inc.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Atinum InvestmentVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
People
Minjae Shin
Executive Officer, Director
Jihoon Park
Executive Officer
Kyunghyun Min
Director
Tae Heum Jeong
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Rockville
United States
HQ
9800 Medical Center Drive, Suite A110
50-200 est. staff
9800 Medical Center Drive, Suite A110, Rockville, MD 20850